InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed a Form 6-K for November 2023. The filing, dated November 8, 2023, announces the Company’s 2023 Annual General Meeting of Shareholders.
- Meeting date: December 14, 2023 at 4:00 p.m. Israel time.
- Location: Offices of the Company’s attorneys in Bnei Brak, Israel.
- Filing status: The Company files annual reports on Form 20-F.
Financial Metrics
This filing is procedural and does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
The filing does not report operating or financial changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide financial guidance, management outlook, risk updates, contingencies, or unusual items. It includes the notice and proxy statement for the annual meeting and a proxy card for shareholders who wish to vote without attending in person.
Investor Verification Checklist
- Review Exhibit 99.1 for the proposals submitted to shareholders and related voting procedures.
- Review Exhibit 99.2 for the proxy card and voting requirements.
- Confirm the annual meeting date, time, location, and applicable record-date or voting instructions in the attached materials.
- Consult the Company’s Form 20-F and other filings for financial performance, liquidity, debt, risks, and outlook, which are not addressed in this Form 6-K.